Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Long survival of congenital alveolar capillary dysplasia patient with NO inhalation and epoprostenol: effect of sildenafil, beraprost and bosentan.

Kodama Y, Tao K, Ishida F, Kawakami T, Tsuchiya K, Ishida K, Takemura T, Nakazawa A, Matsuoka K, Yoda H.

Pediatr Int. 2012 Dec;54(6):923-6. doi: 10.1111/j.1442-200X.2012.03712.x.

PMID:
23279022
2.

[Sildenafil and nitric oxide inhalation in neonatal pulmonary hypertension. Three case reports].

Cavallaro G, Agazzani E, Andaloro L, Bottura C, Cristofori G, Mussini P, Sacco F, Compagnoni G.

Pediatr Med Chir. 2008 May-Jun;30(3):149-55. Italian.

PMID:
19024859
3.

Long-term follow-up after conversion from intravenous epoprostenol to oral therapy with bosentan or sildenafil in 13 patients with pulmonary arterial hypertension.

Johnson RF, Loyd JE, Mullican AL, Fink CA, Robbins IM.

J Heart Lung Transplant. 2007 Apr;26(4):363-9. Epub 2007 Mar 2.

PMID:
17403478
4.

Combination therapy for life-threatening pulmonary hypertension in a premature infant: first report on bosentan use.

Radicioni M, Bruni A, Camerini P.

Eur J Pediatr. 2011 Aug;170(8):1075-8. doi: 10.1007/s00431-011-1422-9. Epub 2011 Mar 8.

PMID:
21380943
5.

Acute and chronic effects of sildenafil in patients with pulmonary arterial hypertension.

Preston IR, Klinger JR, Houtches J, Nelson D, Farber HW, Hill NS.

Respir Med. 2005 Dec;99(12):1501-10.

6.

[Sildenafil in neonate pulmonary hypertension: the opinion of neonatology physician].

Condò V, Colnaghi MR, Mosca E.

Pediatr Med Chir. 2008 May-Jun;30(3):156-8. Italian. No abstract available.

PMID:
19024860
7.

Bosentan and sildenafil: should the combination therapy be a valid alternative in childhood to prostacyclin infusion?

Brancaccio G, Toscano A, Bevilacqua M, Di Chiara L, Parisi F.

Pediatr Transplant. 2007 Feb;11(1):110-2.

PMID:
17239133
8.

Sildenafil and beraprost combination therapy in patients with pulmonary hypertension undergoing valvular heart surgery.

Kim SY, Shim JK, Shim YH, Hong SW, Choi KH, Kwak YL.

J Heart Valve Dis. 2010 May;19(3):333-40.

PMID:
20583396
9.

Inhaled prostacyclin for term infants with persistent pulmonary hypertension refractory to inhaled nitric oxide.

Kelly LK, Porta NF, Goodman DM, Carroll CL, Steinhorn RH.

J Pediatr. 2002 Dec;141(6):830-2.

PMID:
12461501
10.

The use of sildenafil in the treatment of persistent pulmonary hypertension of the newborn: a review of the literature.

Iacovidou N, Syggelou A, Fanos V, Xanthos T.

Curr Pharm Des. 2012;18(21):3034-45. Review.

PMID:
22564297
11.

Transient effect of epoprostenol and sildenafil combined with iNO for pulmonary hypertension in congenital diaphragmatic hernia.

De Luca D, Zecca E, Vento G, De Carolis MP, Romagnoli C.

Paediatr Anaesth. 2006 May;16(5):597-8. No abstract available. Erratum in: Paediatr Anaesth. 2007 Mar;17(3):306. Daniele, De Luca [corrected to De Luca, Daniele]; Pia, De Carolis Maria [corrected to De Carolis, Maria Pia]; Constantino, Romagnoli [corrected to Romagnoli, Constantino].

PMID:
16677275
12.

Pulmonary vasodilator therapy in the NICU: inhaled nitric oxide, sildenafil, and other pulmonary vasodilating agents.

Porta NF, Steinhorn RH.

Clin Perinatol. 2012 Mar;39(1):149-64. doi: 10.1016/j.clp.2011.12.006. Review.

13.

Combination therapy with oral sildenafil and beraprost for pulmonary arterial hypertension associated with CREST syndrome.

Miwa K, Matsubara T, Uno Y, Yasuda T, Sakata K, Tsuda T, Kanaya H.

Int Heart J. 2007 May;48(3):417-22.

14.

Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial.

McLaughlin VV, Benza RL, Rubin LJ, Channick RN, Voswinckel R, Tapson VF, Robbins IM, Olschewski H, Rubenfire M, Seeger W.

J Am Coll Cardiol. 2010 May 4;55(18):1915-22. doi: 10.1016/j.jacc.2010.01.027.

15.
16.

Therapeutic combination of sildenafil and iloprost in a preterm neonate with pulmonary hypertension.

Gürakan B, Kayiran P, Oztürk N, Kayiran SM, Dindar A.

Pediatr Pulmonol. 2011 Jun;46(6):617-20. doi: 10.1002/ppul.21415. Epub 2011 Mar 24.

PMID:
21438177
17.

PPHN: is sildenafil the new nitric? A review of the literature.

Spillers J.

Adv Neonatal Care. 2010 Apr;10(2):69-74. doi: 10.1097/ANC.0b013e3181d5c501. Review.

PMID:
20386371
18.

Sarcoidosis-associated pulmonary hypertension: acute vasoresponsiveness to inhaled nitric oxide and the relation to long-term effect of sildenafil.

Milman N, Svendsen CB, Iversen M, Videbaek R, Carlsen J.

Clin Respir J. 2009 Oct;3(4):207-13. doi: 10.1111/j.1752-699X.2008.00120.x.

PMID:
20298406
19.

Update on PPHN: mechanisms and treatment.

Nair J, Lakshminrusimha S.

Semin Perinatol. 2014 Mar;38(2):78-91. doi: 10.1053/j.semperi.2013.11.004.

20.

Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial.

Simonneau G, Rubin LJ, Galiè N, Barst RJ, Fleming TR, Frost AE, Engel PJ, Kramer MR, Burgess G, Collings L, Cossons N, Sitbon O, Badesch DB; PACES Study Group.

Ann Intern Med. 2008 Oct 21;149(8):521-30. Erratum in: Ann Intern Med. 2009 Jan 6;150(1):63. Ann Intern Med. 2009 Sep 15;151(6):435.

PMID:
18936500

Supplemental Content

Support Center